Mindfulness-Music Intervention in Reducing Anxiety and Stress in Adolescents and Young Adults Receiving Cancer Treatment
This trial studies how well a mindfulness-music intervention works in reducing anxiety and stress in adolescents and young adults receiving cancer treatment. A program designed to incorporate music-based meditation practices and music making activities (e.g., guitar, drums) may help to promote relaxation during cancer treatment.
- Have a diagnosis of any cancer
- Have begun treatment for cancer and plan to receive active cancer treatment (e.g., radiation, chemotherapy, or oral chemotherapy) over the next eight weeks
- Signed informed consent/assent
- Willingness to participate in all study activities
- Speak/read English
- Prognosis < 3 months
- Self-report inability to physically interact with musical instruments (e.g., hold instruments)
- Documentation of significant hearing impairment (e.g., deaf)
Locations & Contacts
Trial Objectives and Outline
I. Determine the feasibility of adolescents and young adults (AYA) recruitment and adherence to a twelve-week mindfulness-music intervention during cancer treatment.
Ia. Explore AYAs’ perspectives of acceptability and satisfaction with participation in a twelve-week mindfulness-music intervention during cancer treatment.
Ib. Examine potential participants’ reasons for declining participation in a twelve-week mindfulness-music intervention during cancer treatment.
II. Evaluate the impact of a twelve-week mindfulness-music therapy intervention to reduce anxiety and stress in AYAs receiving cancer treatment.
IIa. Explore the impact of a twelve-week mindfulness-music therapy intervention to improve fatigue, depression, social/role functioning, pain intensity, pain interference, and sleep-disturbance.
III. Explore demographic and clinical factors that moderate the impact of a twelve-week mindfulness-music therapy intervention on anxiety and stress severity in AYAs receiving cancer treatment.
IV. Examine the internal consistency reliability and content validity of the Patient Reported Outcomes Measurement Information System (PROMIS) Anxiety 4a and Perceived Stress Scale in adolescents and young adults receiving cancer treatment.
Patients attend 4 in-person sessions over 45 minutes each over 12 weeks.
Trial Phase & Type
No phase specified
Dana-Farber Harvard Cancer Center
Robert J Knoerl
Secondary IDs NCI-2018-03554
Clinicaltrials.gov ID NCT03709225